Andrew Booth - Chief Financial Officer at AbCellera Biologics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
ABCL on Nasdaq
All Insider Reports
All Insider Reports

Andrew Booth - trading volume in the past year for AbCellera Biologics Inc.

Holdings reported by Andrew Booth for AbCellera Biologics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 195,600 $668,952 $3.42 27 Feb 2026 Direct
Common Shares 130,959 $505,501 $3.86 27 Feb 2026 By spouse
Share option (right to buy) 8,751,849 01 Jan 2026 Direct Common Shares

Transactions reported by Andrew Booth for AbCellera Biologics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.